Stock & Company Details
Cerus Corp. $CERS
Price:
N/A
N/A
202M
$488M
52 Week High:
N/A
10 Day Average Volume:
N/A
-70.52
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CERS technical indicators
Latest Cerus Corp. (CERS) indicator readings as of 2026-10-29.
CERS's 14-day RSI is 55.0, in neutral territory. At $2.44 it is trading 0.5% below its 200-day moving average of $2.45, and below its 50-day average of $2.48. Price sits near the upper Bollinger Band ($2.18 to $2.44). ADX reads 20.8, sitting between trending and range-bound.
Overview
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
Finance Bot
Ask your questions
Start by typing a question below.
